Its overexpression in cervical cancer suppressed apoptosis both independently and by increasing Bcl-2 protective activity, which further increased the resistance of cervical carcinoma to the effect of DNA-damaging agents [14]. This evidence concerns the gene BCL2 and cervical carcinoma.